Delivery Order SPE2DB22D3501-SPE2DB25FWK21
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on September 29, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on August 29, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count supply) on August 26, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) valued at $17,968.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 29, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $35,936.78 delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Welireg 40 mg, a pharmaceutical product, with performance in Conshohocken, Pennsylvania and completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, represents a non-competitive, competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a $17,968.39 delivery order by the Defense Logistics Agency on August 21, 2025, for the supply of Welireg 40 mg tablets (90-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open solicitation process. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $35,936.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on September 18, 2025, with an ultimate completion date of October 9, 2025. The award is unclassified as a set-aside contract and represents a competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The delivery order...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWK21Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for 90-count tablets of Welireg 40 mg, with a firm fixed price and delivery completion by August 4, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 7/14/25 |